Biogen Inc
NASDAQ:BIIB

Watchlist Manager
Biogen Inc Logo
Biogen Inc
NASDAQ:BIIB
Watchlist
Price: 146.47 USD -0.62% Market Closed
Market Cap: 21.3B USD
Have any thoughts about
Biogen Inc?
Write Note

EV/FCFF
Enterprise Value to FCFF

13.6
Current
23.9
Median
3.9
Industry
Lower than median
Higher than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
13.6
=
Enterprise Value
24.1B USD
/
FCFF
1.8B USD
All Countries
Close
Market Cap EV/FCFF
US
Biogen Inc
NASDAQ:BIIB
21.2B USD 13.6
FR
Pharnext SCA
OTC:PNEXF
6T USD -238 369.5
US
Abbvie Inc
NYSE:ABBV
310.3B USD 23.1
US
Amgen Inc
NASDAQ:AMGN
141.6B USD 30.1
US
Gilead Sciences Inc
NASDAQ:GILD
115.3B USD 11
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD -70.1
US
Epizyme Inc
F:EPE
94.1B EUR -470.6
AU
CSL Ltd
ASX:CSL
134.4B AUD 62.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD 21.1
US
Seagen Inc
F:SGT
39.3B EUR -56.8
NL
argenx SE
XBRU:ARGX
35.8B EUR -105.2

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More